Carroll Financial Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $9.2M | Buy |
155,325
+14,347
| +10% | +$711K | 0.49% | 35 |
|
|
2021
Q3 | $6.06M | Sell |
140,978
-1,949
| -1% | -$86.3K | 0.34% | 51 |
|
|
2021
Q2 | $5.6M | Sell |
142,927
-1,908
| -1% | -$74.2K | 0.32% | 50 |
|
|
2021
Q1 | $5.25M | Sell |
144,835
-5,975
| -4% | -$212K | 0.32% | 53 |
|
|
2020
Q4 | $5.55M | Sell |
150,810
-7,015
| -4% | -$257K | 0.37% | 45 |
|
|
2020
Q3 | $5.5M | Sell |
157,825
-5,511
| -3% | -$193K | 0.42% | 37 |
|
|
2020
Q2 | $5.07M | Sell |
163,336
-1,982
| -1% | -$67.3K | 0.42% | 37 |
|
|
2020
Q1 | $5.12M | Sell |
165,318
-13,683
| -8% | -$466K | 0.5% | 33 |
|
|
2019
Q4 | $6.65M | Sell |
179,001
-27,558
| -13% | -$982K | 0.53% | 31 |
|
|
2019
Q3 | $7.04M | Sell |
206,559
-4,672
| -2% | -$170K | 0.62% | 24 |
|
|
2019
Q2 | $8.68M | Buy |
211,231
+326
| +0.2% | +$12.9K | 0.76% | 23 |
|
|
2019
Q1 | $8.5M | Buy |
210,905
+7,563
| +4% | +$303K | 0.8% | 21 |
|
|
2018
Q4 | $8.34M | Sell |
203,342
-6,300
| -3% | -$262K | 0.93% | 18 |
|
|
2018
Q3 | $8.77M | Sell |
209,642
-18,621
| -8% | -$717K | 0.93% | 20 |
|
|
2018
Q2 | $7.86M | Sell |
228,263
-8,625
| -4% | -$295K | 0.84% | 23 |
|
|
2018
Q1 | $7.98M | Sell |
236,888
-4,694
| -2% | -$161K | 0.88% | 23 |
|
|
2017
Q4 | $8.3M | Sell |
241,582
-6,255
| -3% | -$213K | 0.91% | 24 |
|
|
2017
Q3 | $8.46M | Buy |
247,837
+15,636
| +7% | +$503K | 0.96% | 22 |
|
|
2017
Q2 | $7.4M | Buy |
232,201
+23,699
| +11% | +$747K | 0.89% | 26 |
|
|
2017
Q1 | $6.77M | Buy |
208,502
+52,747
| +34% | +$1.66M | 0.86% | 27 |
|
|
2016
Q4 | $4.8M | Buy |
155,755
+7,158
| +5% | +$219K | 0.68% | 29 |
|
|
2016
Q3 | $4.78M | Buy |
148,597
+13,017
| +10% | +$435K | 0.72% | 27 |
|
|
2016
Q2 | $4.53M | Buy |
135,580
+5,057
| +4% | +$161K | 0.76% | 28 |
|
|
2016
Q1 | $3.67M | Buy |
130,523
+4,082
| +3% | +$117K | 0.68% | 29 |
|
|
2015
Q4 | $3.87M | Sell |
126,441
-1,687
| -1% | -$53.1K | 0.81% | 28 |
|
|
2015
Q3 | $4.07M | Buy |
128,128
+3,014
| +2% | +$96.6K | 0.9% | 26 |
|
|
2015
Q2 | $3.98M | Buy |
125,114
+59,029
| +89% | +$1.92M | 0.89% | 26 |
|
|
2015
Q1 | $2.18M | Buy |
66,085
+25,670
| +64% | +$816K | 0.96% | 20 |
|
|
2014
Q4 | $1.23M | Sell |
40,415
-67,398
| -63% | -$1.93M | 0.78% | 25 |
|
|
2014
Q3 | $3.1M | Sell |
107,813
-10,114
| -9% | -$284K | 0.96% | 22 |
|
|
2014
Q2 | $3.32M | Buy |
117,927
+353
| +0.3% | +$10.1K | 0.93% | 22 |
|
|
2014
Q1 | $3.58M | Buy |
117,574
+6,049
| +5% | +$180K | 1.18% | 19 |
|
|
2013
Q4 | $3.24M | Sell |
111,525
-11,437
| -9% | -$333K | 1.15% | 18 |
|
|
2013
Q3 | $3.35M | Sell |
122,962
-3,997
| -3% | -$109K | 1.26% | 16 |
|
|
2013
Q2 | $3.37M | Buy |
+126,959
| New | +$3.51M | 1.65% | 13 |
|
Other funds holding PFE
Carroll Financial Associates's PFE Position: Q4 2021 in Review
Carroll Financial Associates increased its Pfizer (PFE) stake by 10% in Q4 2021, buying an estimated $711K and bringing the position to 155,325 shares worth $9.2M. The position accounts for 0.49% of the portfolio, ranked #35.
Carroll Financial Associates first reported a position in PFE in Q2 2013 and has held it in 35 quarters since. 3,262 funds tracked by Wall St. Rank hold PFE as of Q4 2021.
- Carroll Financial Associates held 155,325 shares of Pfizer worth $9.2M as of Q4 2021.
- Carroll Financial Associates bought 14,347 Pfizer shares in Q4 2021, an estimated $711K.
- Pfizer made up 0.49% of Carroll Financial Associates's portfolio in Q4 2021, its #35 holding.
- Carroll Financial Associates first reported a position in Pfizer in Q2 2013 and has held it in 35 quarters since.
- 3,262 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.
Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.